Atara生物治療ATRA
那斯達克 · USD
10.42
+0.56
(+5.68%)
收盤 06/12 03:59 (UTC+8)
06/12 03:59 (UTC+8)
Atara生物治療ATRA
10.42
+0.56
(+5.68%)
財務數據
損益表
- 0.04
- 0.27
- 0.29
- 0.40
- 0.33
- 0.98
- 0.18
- 0.03
- 0.02
- 0.01
- 98.88
- 543.39
- 4.69
- 40.33
- -18.50
- 199.66
- -82.09
- -80.35
- -53.81
- -67.65
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 516 | 1,595 | 3,453 | 17,575 | 98,149 | 32,753 | 40,190 | 28,640 | 27,357 | 4,252 |
營業成本 | 124 | 104 | 115 | 554 | 20,439 | 6,795 | 7,602 | 4,627 | 1,985 | 3,160 |
營業毛利 | 392 | 1,491 | 3,338 | 17,021 | 77,710 | 25,958 | 32,588 | 24,013 | 25,372 | 1,092 |
營業費用 | 3,761 | 4,054 | 6,912 | 13,824 | - | - | - | 42,244 | 56,619 | 61,054 |
研發費用 | 164 | -223 | 2,925 | 7,310 | 27,433 | 28,721 | 43,924 | 33,332 | 45,506 | 49,600 |
推銷及管理費用 | 3,597 | 4,277 | 3,987 | 6,514 | 11,475 | 9,440 | 10,421 | 8,912 | 11,113 | 11,454 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -3,369 | -2,563 | -3,574 | 3,197 | 38,802 | -12,203 | -21,757 | -18,231 | -31,247 | -59,962 |
其他收入及費用 | 54 | 51 | 208 | 165 | 225 | 508 | 1,014 | 444 | 672 | 699 |
利息費用 | 830 | 894 | 909 | 972 | 1,017 | 1,017 | 1,183 | 1,262 | 1,153 | 1,176 |
稅前純益 | -4,145 | -3,406 | -4,275 | 2,390 | 38,010 | -12,712 | -21,926 | -19,049 | -31,728 | -60,439 |
所得稅 | - | - | 28 | 3 | - | -19 | -17 | - | 24 | 11 |
稅後純益 | -4,145 | -3,406 | -4,303 | 2,387 | 38,010 | -12,693 | -21,909 | -19,049 | -31,752 | -60,450 |
基本每股稅後盈餘(元) | -0.29 | -0.80 | -0.32 | 0.20 | 3.53 | -1.19 | -2.93 | -3.10 | -0.23 | - |
稀釋每股稅後盈餘(元) | -0.29 | -0.36 | -0.56 | -0.01 | 3.50 | -0.07 | -2.70 | -2.99 | -0.23 | -0.56 |
基本平均股數(千股) | 14081.00 | 13651.00 | 13564.00 | 12197.00 | 10764.00 | 10690.00 | 7466.00 | 6143.00 | 140575.00 | - |
稀釋平均股數(千股) | 14081.00 | 14147.00 | 13564.00 | 12310.00 | 10851.00 | 10690.00 | 7466.00 | 6143.00 | 140575.00 | - |
還原基本每股稅後盈餘(元) | -0.29 | -0.80 | -0.32 | 0.20 | 3.53 | -1.19 | -2.93 | -3.10 | -5.65 | - |
還原稀釋每股稅後盈餘(元) | -0.29 | -0.36 | -0.56 | -0.01 | 3.50 | -0.07 | -2.70 | -2.99 | -5.65 | -13.92 |
還原基本平均股數(千股) | 14,081 | 13,651 | 13,564 | 12,197 | 10,764 | 10,690 | 7,466 | 6,143 | 5,623 | - |
還原稀釋平均股數(千股) | 14,081 | 14,147 | 13,564 | 12,310 | 10,851 | 10,690 | 7,466 | 6,143 | 5,623 | - |
EBITDA(千元) | -2,472 | -1,501 | -2,522 | 4,554 | 41,933 | -9,876 | -18,483 | -15,420 | -28,101 | -54,883 |